T4	B-Entity	B-Entity	0	2	NF	NF	B-NP	NN	B-protein	4	NMOD	B-protein
T4	I-Entity	I-Entity	2	3	-	-	O	HYPH	I-protein	4	P	I-protein
T4	I-Entity	I-Entity	3	8	kappa	kappa	B-NP	NN	I-protein	4	NMOD	I-protein
T4	I-Entity	I-Entity	9	10	B	B	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	10	11	-	-	B-NP	HYPH	O	7	P	O
O	O	O	11	22	independent	independent	I-NP	JJ	O	7	NMOD	O
O	O	O	23	34	suppression	suppression	I-NP	NN	O	0	ROOT	O
O	O	O	35	37	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	38	41	HIV	HIV	B-NP	NN	O	10	NMOD	O
O	O	O	42	52	expression	expression	I-NP	NN	O	8	PMOD	O
O	O	O	53	55	by	by	B-PP	IN	O	7	NMOD	O
O	O	O	56	64	ascorbic	ascorbic	B-NP	JJ	O	13	NMOD	O
O	O	O	65	69	acid	acid	I-NP	NN	O	11	PMOD	O
O	O	O	69	70	.	.	O	.	O	7	P	O

O	O	O	72	80	Ascorbic	Ascorbic	B-NP	JJ	O	2	NMOD	O
O	O	O	81	85	acid	acid	I-NP	NN	O	9	SUB	O
O	O	O	86	87	(	(	O	(	O	8	DEP	O
O	O	O	87	96	ascorbate	ascorbate	B-NP	NN	O	7	NMOD	O
O	O	O	97	99	or	or	O	CC	O	7	NMOD	O
O	O	O	100	107	vitamin	vitamin	B-NP	NN	O	7	NMOD	O
O	O	O	108	109	C	C	I-NP	NN	O	8	DEP	O
O	O	O	109	110	)	)	O	)	O	2	NMOD	O
O	O	O	111	114	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	115	119	been	be	I-VP	VBN	O	9	VC	O
O	O	O	120	125	shown	show	I-VP	VBN	O	10	VC	O
O	O	O	126	128	to	to	I-VP	TO	O	13	VMOD	O
O	O	O	129	137	suppress	suppress	I-VP	VB	O	11	VMOD	O
O	O	O	138	141	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	142	151	induction	induction	I-NP	NN	O	13	OBJ	O
O	O	O	152	154	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	155	158	HIV	HIV	B-NP	NN	O	16	PMOD	O
O	O	O	159	161	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	162	170	latently	latently	B-NP	RB	B-cell_type	23	NMOD	B-cell_type
O	O	O	171	179	infected	infected	I-NP	JJ	I-cell_type	23	NMOD	I-cell_type
O	O	O	180	181	T	T	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	O	182	193	lymphocytic	lymphocytic	I-NP	JJ	I-cell_type	23	NMOD	I-cell_type
O	O	O	194	199	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	O	200	209	following	follow	B-PP	VBG	O	13	VMOD	O
O	O	O	210	221	stimulation	stimulation	B-NP	NN	O	24	PMOD	O
O	O	O	222	226	with	with	B-PP	IN	O	25	NMOD	O
O	O	O	227	228	a	a	B-NP	DT	O	29	NMOD	O
O	O	O	229	234	tumor	tumor	I-NP	NN	B-DNA	29	NMOD	B-DNA
O	O	O	235	243	promoter	promoter	I-NP	NN	I-DNA	35	NMOD	I-DNA
O	O	O	244	245	(	(	O	(	O	32	DEP	O
O	O	O	245	248	PMA	PMA	B-NP	NN	O	32	DEP	O
O	O	O	248	249	)	)	O	)	O	29	NMOD	O
O	O	O	250	253	and	and	O	CC	O	35	NMOD	O
O	O	O	254	266	inflammatory	inflammatory	B-NP	JJ	B-protein	35	NMOD	B-protein
O	O	O	267	275	cytokine	cytokine	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	O	276	277	(	(	O	(	O	40	DEP	O
T1	B-Protein	B-Protein	277	280	TNF	TNF	B-NP	NN	B-protein	39	NMOD	B-protein
T1	I-Protein	I-Protein	280	281	-	-	O	HYPH	I-protein	39	P	I-protein
T1	I-Protein	I-Protein	281	286	alpha	alpha	B-NP	SYM	I-protein	40	DEP	I-protein
O	O	O	286	287	)	)	O	)	O	35	NMOD	O
O	O	O	287	288	.	.	O	.	O	9	P	O

O	O	O	289	291	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	292	298	assess	assess	I-VP	VB	O	22	VMOD	O
O	O	O	299	306	whether	whether	B-SBAR	IN	O	2	VMOD	O
O	O	O	307	311	this	this	B-NP	DT	O	5	NMOD	O
O	O	O	312	322	inhibition	inhibition	I-NP	NN	O	6	SUB	O
O	O	O	323	326	was	be	B-VP	VBD	O	3	SBAR	O
O	O	O	327	335	mediated	mediate	I-VP	VBN	O	6	VC	O
O	O	O	336	339	via	via	B-PP	IN	O	7	VMOD	O
O	O	O	340	350	modulation	modulation	B-NP	NN	O	8	PMOD	O
O	O	O	351	353	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	354	357	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	358	366	cellular	cellular	I-NP	JJ	B-protein	14	NMOD	B-protein
O	O	O	367	380	transcription	transcription	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	381	387	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	387	388	,	,	O	,	O	19	P	O
T5	B-Entity	B-Entity	389	391	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T5	I-Entity	I-Entity	391	392	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T5	I-Entity	I-Entity	392	397	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T5	I-Entity	I-Entity	398	399	B	B	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	399	400	,	,	O	,	O	22	P	O
O	O	O	401	403	we	we	B-NP	PRP	O	22	SUB	O
O	O	O	404	411	carried	carry	B-VP	VBD	O	0	ROOT	O
O	O	O	412	415	out	out	B-PRT	RP	O	22	VMOD	O
O	O	O	416	419	gel	gel	B-NP	NN	O	26	NMOD	O
O	O	O	420	425	shift	shift	I-NP	NN	O	26	NMOD	O
O	O	O	426	434	analysis	analysis	I-NP	NN	O	22	OBJ	O
O	O	O	435	437	on	on	B-PP	IN	O	26	NMOD	O
O	O	O	438	445	nuclear	nuclear	B-NP	JJ	O	29	NMOD	O
O	O	O	446	454	extracts	extract	I-NP	NNS	O	27	PMOD	O
O	O	O	455	463	prepared	prepare	B-VP	VBN	O	29	NMOD	O
O	O	O	464	469	under	under	B-PP	IN	O	30	VMOD	O
O	O	O	470	479	different	different	B-NP	JJ	O	33	NMOD	O
O	O	O	480	490	conditions	condition	I-NP	NNS	O	31	PMOD	O
O	O	O	491	493	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	494	498	cell	cell	B-NP	NN	O	36	NMOD	O
O	O	O	499	510	stimulation	stimulation	I-NP	NN	O	34	PMOD	O
O	O	O	511	513	in	in	B-PP	IN	O	36	NMOD	O
O	O	O	514	517	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	518	526	presence	presence	I-NP	NN	O	41	NMOD	O
O	O	O	527	529	or	or	I-NP	CC	O	41	NMOD	O
O	O	O	530	537	absence	absence	I-NP	NN	O	37	PMOD	O
O	O	O	538	540	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	541	550	ascorbate	ascorbate	B-NP	NN	O	53	NMOD	O
O	O	O	550	551	,	,	O	,	O	53	P	O
T6	B-Entity	B-Entity	552	553	N	N	B-NP	NN	O	53	NMOD	O
T6	I-Entity	I-Entity	553	554	-	-	O	HYPH	O	53	P	O
T6	I-Entity	I-Entity	554	568	acetylcysteine	acetylcysteine	B-NP	NN	O	53	NMOD	O
O	O	O	569	570	(	(	O	(	O	50	DEP	O
T7	B-Entity	B-Entity	570	573	NAC	NAC	B-NP	NN	O	50	DEP	O
O	O	O	573	574	)	)	O	)	O	47	NMOD	O
O	O	O	574	575	,	,	O	,	O	53	P	O
O	O	O	576	578	or	or	O	CC	O	53	NMOD	O
O	O	O	579	589	zidovudine	zidovudine	B-NP	NN	O	42	PMOD	O
O	O	O	590	591	(	(	O	(	O	56	DEP	O
O	O	O	591	594	AZT	AZT	B-NP	NN	O	56	DEP	O
O	O	O	594	595	)	)	O	)	O	53	NMOD	O
O	O	O	595	596	.	.	O	.	O	22	P	O

O	O	O	597	609	Pretreatment	Pretreatment	B-NP	NN	O	22	NMOD	O
O	O	O	610	612	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	613	616	ACH	ACH	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	O	616	617	-	-	B-NP	HYPH	I-cell_line	7	P	I-cell_line
O	O	O	617	618	2	2	I-NP	CD	I-cell_line	7	NMOD	I-cell_line
O	O	O	619	620	T	T	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	O	621	626	cells	cell	I-NP	NNS	I-cell_line	2	PMOD	I-cell_line
O	O	O	627	629	by	by	B-PP	IN	O	1	NMOD	O
T8	B-Entity	B-Entity	630	633	NAC	NAC	B-NP	NN	O	8	PMOD	O
O	O	O	634	642	followed	follow	B-VP	VBN	O	1	NMOD	O
O	O	O	643	645	by	by	B-PP	IN	O	10	VMOD	O
O	O	O	646	657	stimulation	stimulation	B-NP	NN	O	11	PMOD	O
O	O	O	658	662	with	with	B-PP	IN	O	12	NMOD	O
O	O	O	663	666	PMA	PMA	B-NP	NN	O	13	PMOD	O
O	O	O	666	667	,	,	O	,	O	22	P	O
T2	B-Protein	B-Protein	668	671	TNF	TNF	B-NP	NN	B-protein	22	NMOD	B-protein
T2	I-Protein	I-Protein	671	672	-	-	O	HYPH	O	22	NMOD	O
T2	I-Protein	I-Protein	672	677	alpha	alpha	B-NP	SYM	O	22	NMOD	O
O	O	O	677	678	,	,	O	,	O	22	P	O
O	O	O	679	681	or	or	O	CC	O	22	NMOD	O
O	O	O	682	690	hydrogen	hydrogen	B-NP	NN	O	22	NMOD	O
O	O	O	691	699	peroxide	peroxide	I-NP	NN	O	26	SUB	O
O	O	O	700	701	(	(	O	(	O	25	DEP	O
O	O	O	701	705	H2O2	H2O2	B-NP	NN	O	25	DEP	O
O	O	O	705	706	)	)	O	)	O	22	NMOD	O
O	O	O	707	715	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	716	718	in	in	B-PP	IN	O	26	VMOD	O
O	O	O	719	725	strong	strong	B-NP	JJ	O	29	NMOD	O
O	O	O	726	737	suppression	suppression	I-NP	NN	O	27	PMOD	O
O	O	O	738	740	of	of	B-PP	IN	O	29	NMOD	O
T9	B-Entity	B-Entity	741	743	NF	NF	B-NP	NN	B-protein	35	NMOD	B-protein
T9	I-Entity	I-Entity	743	744	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
T9	I-Entity	I-Entity	744	749	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
T9	I-Entity	I-Entity	750	751	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	O	752	762	activation	activation	I-NP	NN	O	30	PMOD	O
O	O	O	762	763	.	.	O	.	O	26	P	O

O	O	O	764	766	In	In	B-PP	IN	O	8	VMOD	O
O	O	O	767	775	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	775	776	,	,	O	,	O	8	P	O
O	O	O	777	784	neither	neither	O	CC	O	7	NMOD	O
O	O	O	785	794	ascorbate	ascorbate	B-NP	NN	O	7	NMOD	O
O	O	O	795	798	nor	nor	I-NP	CC	O	7	NMOD	O
O	O	O	799	802	AZT	AZT	I-NP	NN	O	8	SUB	O
O	O	O	803	811	affected	affect	B-VP	VBD	O	0	ROOT	O
T10	B-Entity	B-Entity	812	814	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T10	I-Entity	I-Entity	814	815	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T10	I-Entity	I-Entity	815	820	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
T10	I-Entity	I-Entity	821	822	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	823	831	activity	activity	I-NP	NN	O	8	OBJ	O
O	O	O	832	837	under	under	B-PP	IN	O	8	VMOD	O
O	O	O	838	841	all	all	B-NP	DT	O	18	NMOD	O
O	O	O	842	847	three	three	I-NP	CD	O	18	NMOD	O
O	O	O	848	857	induction	induction	I-NP	NN	O	18	NMOD	O
O	O	O	858	868	conditions	condition	I-NP	NNS	O	14	PMOD	O
O	O	O	869	871	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	872	875	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	876	879	ACH	ACH	I-NP	NN	B-cell_line	25	NMOD	B-cell_line
O	O	O	879	880	-	-	B-NP	HYPH	I-cell_line	25	NMOD	I-cell_line
O	O	O	880	881	2	2	I-NP	CD	I-cell_line	25	NMOD	I-cell_line
O	O	O	882	886	cell	cell	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	887	891	line	line	I-NP	NN	I-cell_line	19	PMOD	I-cell_line
O	O	O	891	892	.	.	O	.	O	8	P	O

O	O	O	893	902	Ascorbate	Ascorbate	B-NP	NN	O	3	NMOD	O
O	O	O	903	906	and	and	I-NP	CC	O	3	NMOD	O
O	O	O	907	910	AZT	AZT	I-NP	NN	O	5	SUB	O
O	O	O	911	915	also	also	B-ADVP	RB	O	5	VMOD	O
O	O	O	916	919	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	920	922	no	no	B-NP	DT	O	7	NMOD	O
O	O	O	923	929	effect	effect	I-NP	NN	O	5	OBJ	O
O	O	O	930	932	on	on	B-PP	IN	O	5	VMOD	O
T11	B-Entity	B-Entity	933	935	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T11	I-Entity	I-Entity	935	936	-	-	I-NP	HYPH	I-protein	12	NMOD	I-protein
T11	I-Entity	I-Entity	936	941	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T11	I-Entity	I-Entity	942	943	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	944	954	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	O	955	964	following	follow	B-PP	VBG	O	13	NMOD	O
T3	B-Protein	B-Protein	965	968	TNF	TNF	B-NP	NN	B-protein	14	PMOD	B-protein
T3	I-Protein	I-Protein	968	969	-	-	O	HYPH	O	17	P	O
T3	I-Protein	I-Protein	969	974	alpha	alpha	O	SYM	O	15	NMOD	O
O	O	O	974	975	-	-	O	HYPH	O	17	VMOD	O
O	O	O	976	978	or	or	O	CC	O	18	DEP	O
O	O	O	979	982	PMA	PMA	B-NP	NN	O	23	NMOD	O
O	O	O	982	983	-	-	O	HYPH	O	20	P	O
O	O	O	983	990	induced	induce	B-NP	VBN	O	23	NMOD	O
O	O	O	991	1002	stimulation	stimulation	I-NP	NN	O	19	PMOD	O
O	O	O	1003	1005	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1006	1008	U1	U1	B-NP	NN	B-cell_line	27	NMOD	B-cell_line
O	O	O	1009	1021	promonocytic	promonocytic	I-NP	JJ	I-cell_line	27	NMOD	I-cell_line
O	O	O	1022	1027	cells	cell	I-NP	NNS	I-cell_line	24	PMOD	I-cell_line
O	O	O	1027	1028	.	.	O	.	O	5	P	O

O	O	O	1029	1034	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1035	1042	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1043	1050	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1051	1055	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1056	1059	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1060	1069	molecular	molecular	I-NP	JJ	O	7	NMOD	O
O	O	O	1070	1079	mechanism	mechanism	I-NP	NN	O	13	SUB	O
O	O	O	1080	1082	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1083	1086	HIV	HIV	B-NP	NN	O	10	NMOD	O
O	O	O	1087	1097	inhibition	inhibition	I-NP	NN	O	8	PMOD	O
O	O	O	1098	1100	by	by	B-PP	IN	O	10	NMOD	O
O	O	O	1101	1110	ascorbate	ascorbate	B-NP	NN	O	11	PMOD	O
O	O	O	1111	1113	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	O	1114	1117	not	not	I-VP	RB	O	13	VMOD	O
O	O	O	1118	1126	mediated	mediate	I-VP	VBN	O	13	VC	O
O	O	O	1127	1130	via	via	B-PP	IN	O	15	VMOD	O
T12	B-Entity	B-Entity	1131	1133	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T12	I-Entity	I-Entity	1133	1134	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T12	I-Entity	I-Entity	1134	1139	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T12	I-Entity	I-Entity	1140	1141	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1142	1152	inhibition	inhibition	I-NP	NN	O	16	PMOD	O
O	O	O	1152	1153	,	,	O	,	O	15	P	O
O	O	O	1154	1160	unlike	unlike	B-PP	IN	O	15	VMOD	O
O	O	O	1161	1165	that	that	B-NP	DT	O	23	PMOD	O
O	O	O	1166	1170	seen	see	B-VP	VBN	O	24	NMOD	O
O	O	O	1171	1175	with	with	B-PP	IN	O	25	VMOD	O
O	O	O	1176	1181	other	other	B-NP	JJ	O	28	NMOD	O
O	O	O	1182	1194	antioxidants	antioxidant	I-NP	NNS	O	26	PMOD	O
O	O	O	1194	1195	.	.	O	.	O	3	P	O
